Table 1. Open in new tab Factors related...

Variables and categories

Odds ratio

P-value

CI 95%

Age group
(years)

<49

Reference

50-59

1.130

.698

0.611

2.088

60-69

1.176

.573

0.669

2.066

≥70

1.011

.970

0.561

1.823

Sex

Men

Reference

Women

1.361

.114

0.929

1.992

Marital status

Married

Reference

Divorced

1.120

.695

0.635

1.977

Single

1.407

.249

0.788

2.512

Widowed

1.945

.013

1.151

3.287

Education

≥High school

Reference

Middle school

1.193

.653

0.553

2.573

Elementary school

0.609

.023

0.396

0.934

No education

1.013

.970

0.534

1.918

Region of origin

Mexico City

Reference

North

1.777

.216

0.715

4.420

Center

1.487

.097

0.931

2.376

South

1.516

.129

0.886

2.593

Primary symptom

Cough

Reference

Dyspnea

2.299

.002

1.369

3.862

Chest pain

1.132

.699

0.604

2.120

Hemoptisis

1.061

.915

0.361

3.119

Weight loss

1.516

.312

0.677

3.395

Other symptoms

1.138

.607

0.696

1.861

Type of lung cancer

Non Small Cell Lung Cancer (NSCLC)

Reference

Small Cell Lung Cancer (SCLC)

0.103

.034

0.013

0.838

Unknown/undetermined

0.441

.083

0.175

1.112

Cancer stages I-IV

I and II

Reference

III

0.825

.648

0.362

1.883

1.137

.689

0.607

2.128

Unknown

0.983

.979

0.264

3.662

Treatment modalities

Single treatment modality (chemo)

Reference

Single treatment modality (immunotherapy)

1.607

.753

0.084

30.781

Single treatment modality (radiotherapy)

0.309

<.0001

0.169

0.562

Single treatment modality (palliative care only)

0.431

.151

0.137

1.359

Single treatment modality (tyrosine kinase inhibitor)

0.626

.095

0.362

1.085

Single treatment modality (other)

4.706

.095

0.764

29.005

Double treatment modality

1.124

.728

0.582

2.171

≥Triple treatment modality

0.192

.035

0.042

0.888

Not specified

0.532

.210

0.199

1.426

Time period of admission

2019-2021

Reference

2013-2018

0.455

.020

0.234

0.885

2007-2012

0.193

<.0001

0.092

0.402

2004-2006

0.890

.769

0.408

1.940

Table 1.

Open in new tab

Factors related with treatment delays of >31 days among Group A individuals who received their diagnostic workup for lung cancer at INCAN (N = 801, R² = 12%).

Variables and categories		Odds ratio	P-value	CI 95%
Age group (years)	<49	Reference
	50-59	1.130	.698	0.611	2.088
	60-69	1.176	.573	0.669	2.066
	≥70	1.011	.970	0.561	1.823
Sex	Men	Reference
Sex	Women	1.361	.114	0.929	1.992
Marital status	Married	Reference
	Divorced	1.120	.695	0.635	1.977
	Single	1.407	.249	0.788	2.512
	Widowed	1.945	.013	1.151	3.287
Education	≥High school	Reference
	Middle school	1.193	.653	0.553	2.573
	Elementary school	0.609	.023	0.396	0.934
	No education	1.013	.970	0.534	1.918
Region of origin	Mexico City	Reference
	North	1.777	.216	0.715	4.420
	Center	1.487	.097	0.931	2.376
	South	1.516	.129	0.886	2.593
Primary symptom	Cough	Reference
	Dyspnea	2.299	.002	1.369	3.862
	Chest pain	1.132	.699	0.604	2.120
	Hemoptisis	1.061	.915	0.361	3.119
	Weight loss	1.516	.312	0.677	3.395
	Other symptoms	1.138	.607	0.696	1.861
Type of lung cancer	Non Small Cell Lung Cancer (NSCLC)	Reference
	Small Cell Lung Cancer (SCLC)	0.103	.034	0.013	0.838
	Unknown/undetermined	0.441	.083	0.175	1.112
Cancer stages I-IV	I and II	Reference
	III	0.825	.648	0.362	1.883
	IV	1.137	.689	0.607	2.128
	Unknown	0.983	.979	0.264	3.662
Treatment modalities	Single treatment modality (chemo)	Reference
	Single treatment modality (immunotherapy)	1.607	.753	0.084	30.781
	Single treatment modality (radiotherapy)	0.309	<.0001	0.169	0.562
	Single treatment modality (palliative care only)	0.431	.151	0.137	1.359
	Single treatment modality (tyrosine kinase inhibitor)	0.626	.095	0.362	1.085
	Single treatment modality (other)	4.706	.095	0.764	29.005
	Double treatment modality	1.124	.728	0.582	2.171
	≥Triple treatment modality	0.192	.035	0.042	0.888
	Not specified	0.532	.210	0.199	1.426
Time period of admission	2019-2021	Reference
	2013-2018	0.455	.020	0.234	0.885
	2007-2012	0.193	<.0001	0.092	0.402
	2004-2006	0.890	.769	0.408	1.940

Variables and categories		Odds ratio	P-value	CI 95%
Age group (years)	<49	Reference
	50-59	1.130	.698	0.611	2.088
	60-69	1.176	.573	0.669	2.066
	≥70	1.011	.970	0.561	1.823
Sex	Men	Reference
Sex	Women	1.361	.114	0.929	1.992
Marital status	Married	Reference
	Divorced	1.120	.695	0.635	1.977
	Single	1.407	.249	0.788	2.512
	Widowed	1.945	.013	1.151	3.287
Education	≥High school	Reference
	Middle school	1.193	.653	0.553	2.573
	Elementary school	0.609	.023	0.396	0.934
	No education	1.013	.970	0.534	1.918
Region of origin	Mexico City	Reference
	North	1.777	.216	0.715	4.420
	Center	1.487	.097	0.931	2.376
	South	1.516	.129	0.886	2.593
Primary symptom	Cough	Reference
	Dyspnea	2.299	.002	1.369	3.862
	Chest pain	1.132	.699	0.604	2.120
	Hemoptisis	1.061	.915	0.361	3.119
	Weight loss	1.516	.312	0.677	3.395
	Other symptoms	1.138	.607	0.696	1.861
Type of lung cancer	Non Small Cell Lung Cancer (NSCLC)	Reference
	Small Cell Lung Cancer (SCLC)	0.103	.034	0.013	0.838
	Unknown/undetermined	0.441	.083	0.175	1.112
Cancer stages I-IV	I and II	Reference
	III	0.825	.648	0.362	1.883
	IV	1.137	.689	0.607	2.128
	Unknown	0.983	.979	0.264	3.662
Treatment modalities	Single treatment modality (chemo)	Reference
	Single treatment modality (immunotherapy)	1.607	.753	0.084	30.781
	Single treatment modality (radiotherapy)	0.309	<.0001	0.169	0.562
	Single treatment modality (palliative care only)	0.431	.151	0.137	1.359
	Single treatment modality (tyrosine kinase inhibitor)	0.626	.095	0.362	1.085
	Single treatment modality (other)	4.706	.095	0.764	29.005
	Double treatment modality	1.124	.728	0.582	2.171
	≥Triple treatment modality	0.192	.035	0.042	0.888
	Not specified	0.532	.210	0.199	1.426
Time period of admission	2019-2021	Reference
	2013-2018	0.455	.020	0.234	0.885
	2007-2012	0.193	<.0001	0.092	0.402
	2004-2006	0.890	.769	0.408	1.940

This Feature Is Available To Subscribers Only